Phase 2CompletedINTERVENTIONAL
AMCPR (Augmented-Medication CardioPulmonary Resuscitation) Trial for OHCA
ClinicalTrials.gov · NCT03191240 · Registry updated: 2022-03-08
- Condition / research focus
- Out-of-Hospital Cardiac Arrest
- Sponsor
- Asan Medical Center
- Countries with listed sites
- South Korea
- Registry dates and results
- Start: 2017-12-31. Completion: 2021-08-31 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Vasopressins (drug) — also listed as: Vasopressin inj
- Normal saline (drug) — also listed as: 0.9% sodium chloride
Where the study takes place — 2 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Chonnam National University Hospital
Gwangju, South Korea
Site recruitment: Not reported